美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Phentermine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Phentermine HCl/Topiramate	Capsule (Extended Release)			Develop a dissolution method			2023/09/15
Phenytoin	Suspension			Refer to USP			2007/06/18
Phenytoin	Tablet (Chewable)			Develop a dissolution method			2024/01/03
Phenytoin Sodium	Capsule			Develop a dissolution method			2024/01/03
Phytonadione	Tablet			Develop a dissolution method			2010/03/25
Pilocarpine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Pimavanserin Tartrate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Pimozide	Tablet			Refer to USP			2008/02/19
Pindolol	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Pioglitazone HCl	Tablet	II (Paddle)	75	HCl-0.3 M KCl Buffer, pH 2.0	900	5, 10, 15 and 30	2004/02/13
Pirfenidone	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Pirfenidone	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Piroxicam	Capsule			Refer to USP			2012/10/04
Pirtobrutinib	Tablet	II (Paddle)	75	Sodium Phosphate Buffer, pH 6.8	900	5, 10, 15, 20, 30, 45 and 60	2024/05/31
Pitavastatin Calcium	Tablet	I (Basket)	35	0.05 M Phosphate Buffer, pH 6.8	900	5, 10, 15, 20, 30 and 45	2010/12/23
Pomalidomide	Capsule	II (Paddle)	50	0.1 N HCl	900	10, 15, 20, 30 and 45	2015/05/28
Ponatinib HCl	Tablet	I (Basket)	50	pH 2.1, KCl/HCl buffer (degassed)	900	10, 15, 20, 30, 45 and 60	2015/09/03
Posaconazole	Oral Suspension	II (Paddle)	25	0.3% SLS	900	10, 20, 30 and 45	2007/12/03
Posaconazole	For Suspension (Delayed Release)	II (Paddle)	75	Acid stage: 0.01 N HCl; Buffer stage: pH 6.8 Phosphate buffer with 1.3% Tween 80;	Acid stage: 750 mL; Buffer stage: 1000 mL	Acid stage: 120; Buffer stage: 5, 10, 15, 20, 30 and 45	2022/07/07